Collegium Pharmaceutical

Collegium Pharmaceutical

World Rank (Aug-2026)
9617
Market Cap (Aug-2026)
0.919 Billion USD
Market Cap (Mar-08-2026)
1.184 Billion USD
World Rank (Jan-05-2024)
8,100
Market Cap (Jan-05-2024)
1.103 Billion USD
World Rank (Jul-30-2023)
10,025
Market Cap (Jul-30-2023)
0.785 Billion USD
World Rank (Jan-07-2022)
11,744
Market Cap (Jan-07-2022)
0.664 Billion USD
World Rank (Jan-01-2021)
9,591
Market Cap (Jan-01-2021)
0.693 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
COLL
Employee Count
234
Employee Count as of Date
As on December 2020
Headquarters City/State
Massachusetts
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
781 Million USD
Annual Operating Income in USD
180 Million USD
Annual Net Income in USD
63 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
1,657 Million USD
Total Liabilities in USD
1,355 Million USD
Total Equity in USD
302 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Pharmaceutical
HealthCare Products
Company Website
COLLEGIUM PHARMACEUTICAL
Yahoo
Yahoo @ Nasdaq
Company Profile

Collegium Pharmaceutical is a Specialty Pharmaceutical company committed to being the leader in responsible pain management. It has been focused on developing and commercializing new medicines for pain management that reflect its core values and commitment to people suffering from pain, providers and communities. The headquarters is in USA.

IPO Year
2015
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share